| Type 2 Diabetes Mellitus |
1 |
1 |
| Child |
0 |
0.99 |
| Hypertension |
0 |
0.39 |
| Heart Failure (HF) |
0 |
0.28 |
| Cardiovascular Risk Management |
0 |
0.2 |
| Coronary Artery Disease (CAD) |
0 |
0.2 |
| Face |
0 |
0.19 |
| Myocardial Infarction (MI) |
0 |
0.18 |
| Pregnancy |
0 |
0.16 |
| Cardiovascular disease |
0 |
0.14 |
| Young Adult |
0 |
0.14 |
| Diabetic Microvascular Complications |
0 |
0.13 |
| New York |
0 |
0.1 |
| Prognosis |
0 |
0.1 |
| Retinal Diseases |
0 |
0.1 |
| SGLT2 Inhibitor |
0 |
0.1 |
| Renal Disease |
0 |
0.08 |
| Congestive Heart Failure |
0 |
0.07 |
| Diabetic Nephropathy |
0 |
0.07 |
| Hemoglobin A1c |
0 |
0.07 |
| Macular Edema |
0 |
0.07 |
| Diabetic Retinopathy |
0 |
0.06 |